ABN AMRO Investment Solutions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279M Buy
232,754
+63,603
+38% +$65M 2.42% 8
2026
Q1
$156M Buy
169,151
+31,877
+23% +$32.3M 2.03% 7
2025
Q4
$148M Buy
137,274
+56,281
+69% +$53.8M 2.18% 7
2025
Q3
$61.8M Sell
80,993
-12,380
-13% -$9.21M 1.27% 19
2025
Q2
$72.8M Buy
93,373
+3,408
+4% +$2.65M 1.46% 14
2025
Q1
$74.3M Buy
89,965
+6,947
+8% +$5.78M 1.55% 13
2024
Q4
$64.1M Buy
83,018
+69,676
+522% +$57.7M 1.19% 23
2024
Q3
$11.8M Sell
13,342
-689
-5% -$619K 0.21% 93
2024
Q2
$12.7M Sell
14,031
-15
-0.1% -$12K 0.23% 87
2024
Q1
$10.9M Buy
14,046
+148
+1% +$105K 0.19% 96
2023
Q4
$8.1M Sell
13,898
-1,338
-9% -$781K 0.14% 126
2023
Q3
$8.18M Buy
15,236
+6,014
+65% +$3.1M 0.16% 121
2023
Q2
$4.32M Sell
9,222
-554
-6% -$232K 0.09% 169
2023
Q1
$3.36M Buy
+9,776
New +$3.3M 0.07% 204

Other funds holding LLY

ABN AMRO Investment Solutions's LLY Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its Eli Lilly (LLY) stake by 38% in Q2 2026, buying an estimated $65M and bringing the position to 232,754 shares worth $279M. The position accounts for 2.42% of the portfolio, ranked #8.

ABN AMRO Investment Solutions first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • ABN AMRO Investment Solutions held 232,754 shares of Eli Lilly worth $279M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 63,603 Eli Lilly shares in Q2 2026, an estimated $65M.
  • Eli Lilly made up 2.42% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #8 holding.
  • ABN AMRO Investment Solutions first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.